Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control study

Fig. 3

Incidence of neutropenia amongst the PK and BSA groups. From the fourth treatment cycle, the incidence of grade 3 and above neutropenia in the PK group was significantly lower than that in the BSA group. *, P < 0.05 compared with the BSA group; **, P < 0.01 compared with the BSA group

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us